PCI Biotech Holding ASA (OSL: PCIB)
Norway
· Delayed Price · Currency is NOK 1.850
+0.050 (2.78%)
Aug 30, 2024, 4:25 PM CET
PCI Biotech Holding ASA Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 30.54 | 41.18 | 56.6 | 116.12 | 187.97 | 261.1 | Upgrade
|
| Cash & Short-Term Investments | 30.54 | 41.18 | 56.6 | 116.12 | 187.97 | 261.1 | Upgrade
|
| Cash Growth | -33.00% | -27.23% | -51.26% | -38.22% | -28.01% | -25.26% | Upgrade
|
| Other Receivables | 6.41 | 2.57 | 6.16 | 5.1 | 5.99 | 7.01 | Upgrade
|
| Receivables | 6.41 | 2.57 | 6.16 | 5.1 | 5.99 | 7.01 | Upgrade
|
| Prepaid Expenses | - | - | - | 7.1 | 7.18 | 7.63 | Upgrade
|
| Other Current Assets | -0 | -0 | - | - | - | - | Upgrade
|
| Total Current Assets | 36.95 | 43.75 | 62.76 | 128.32 | 201.13 | 275.75 | Upgrade
|
| Property, Plant & Equipment | 0.46 | 0.3 | 0.72 | 7.66 | 7.99 | 6.28 | Upgrade
|
| Other Long-Term Assets | 0 | - | 0 | - | 0 | - | Upgrade
|
| Total Assets | 37.41 | 44.05 | 63.48 | 135.98 | 209.12 | 282.03 | Upgrade
|
| Accounts Payable | 1.52 | 0.71 | 0.5 | 3.75 | 5.19 | 8.6 | Upgrade
|
| Accrued Expenses | - | 3.94 | 4.82 | 15.93 | 13.98 | 15.37 | Upgrade
|
| Current Portion of Leases | 0.37 | 0.32 | 0.44 | 0.63 | 0.67 | 0.66 | Upgrade
|
| Other Current Liabilities | 3.49 | - | -0 | 0.61 | -0 | 0 | Upgrade
|
| Total Current Liabilities | 5.39 | 4.97 | 5.75 | 20.91 | 19.85 | 24.63 | Upgrade
|
| Long-Term Leases | 0.11 | - | 0.33 | 1.28 | - | 0.54 | Upgrade
|
| Other Long-Term Liabilities | 0.02 | 0.03 | - | - | 0.03 | 2.04 | Upgrade
|
| Total Liabilities | 5.51 | 5.01 | 6.08 | 22.19 | 19.88 | 27.2 | Upgrade
|
| Common Stock | 1.12 | 1.12 | 111.98 | 111.98 | 111.98 | 111.8 | Upgrade
|
| Additional Paid-In Capital | - | 37.92 | - | 450.46 | 450.46 | 450.33 | Upgrade
|
| Retained Earnings | - | - | -54.58 | -448.65 | -373.2 | -307.3 | Upgrade
|
| Comprensive Income & Other | 30.79 | 0 | 0 | -0 | - | -0 | Upgrade
|
| Shareholders' Equity | 31.91 | 39.04 | 57.4 | 113.79 | 189.24 | 254.83 | Upgrade
|
| Total Liabilities & Equity | 37.41 | 44.05 | 63.48 | 135.98 | 209.12 | 282.03 | Upgrade
|
| Total Debt | 0.48 | 0.32 | 0.77 | 1.91 | 0.67 | 1.2 | Upgrade
|
| Net Cash (Debt) | 30.06 | 40.87 | 55.83 | 114.21 | 187.29 | 259.91 | Upgrade
|
| Net Cash Growth | -33.21% | -26.80% | -51.12% | -39.02% | -27.94% | -25.60% | Upgrade
|
| Net Cash Per Share | - | 1.09 | 1.50 | 3.06 | 5.02 | 6.97 | Upgrade
|
| Filing Date Shares Outstanding | - | 37.33 | 37.33 | 37.33 | 37.33 | 37.27 | Upgrade
|
| Total Common Shares Outstanding | - | 37.33 | 37.33 | 37.33 | 37.33 | 37.27 | Upgrade
|
| Working Capital | 31.56 | 38.78 | 57.01 | 107.41 | 181.28 | 251.12 | Upgrade
|
| Book Value Per Share | - | 1.05 | 1.54 | 3.05 | 5.07 | 6.84 | Upgrade
|
| Tangible Book Value | 31.91 | 39.04 | 57.4 | 113.79 | 189.24 | 254.83 | Upgrade
|
| Tangible Book Value Per Share | - | 1.05 | 1.54 | 3.05 | 5.07 | 6.84 | Upgrade
|
| Machinery | - | - | 10 | 10 | 9.66 | 5.74 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.